ConductScience.org, home

Paper36906290

Noninvasive quantitative evaluation of viable islet grafts using 111 In-exendin-4 SPECT/CT.

Botagarova A and 7 others. FASEB J, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Noninvasive quantitative evaluation of viable islet grafts using 111 In-exendin-4 SPECT/CT. Papers, record 36906290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Noninvasive quantitative evaluation of viable islet grafts using 111 In-exendin-4 SPECT/CT.
PubMed
Journal
FASEB J
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2025-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Botagarova AAinurhttps://orcid.org/0000-0001-5610-4659
2Murakami TTakaakihttps://orcid.org/0000-0003-3844-1138
3Fujimoto HHiroyuki
4Fauzi MMuhammad
5Kiyobayashi SSakura
6Otani DDaisuke
7Fujimoto NNanae
8Inagaki NNobuya

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, ExperimentalMajor topic
Islets of Langerhans TransplantationMajor topic
Mice
Animals
Exenatide
Peptides
Insulin
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116707190SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes.Diabetes Res Clin Pract2006https://conductscience.org/library/papers/16707190PubMed
224599112Inside the pancreas: progress and challenges of human beta cell mass quantification.Diabetologia2014https://conductscience.org/library/papers/24599112PubMed
333759815Type 1 diabetes mellitus: much progress, many opportunities.J Clin Invest2021https://conductscience.org/library/papers/33759815PubMed
435407339Magnetic Resonance Imaging of Transplanted Porcine Neonatal Pancreatic Cell Clusters Labeled with Exendin-4-Conjugated Manganese Magnetism-Engineered Iron Oxide Nanoparticles.Nanomaterials (Basel)2022https://conductscience.org/library/papers/35407339PubMed
515983207Five-year follow-up after clinical islet transplantation.Diabetes2005https://conductscience.org/library/papers/15983207PubMed
626795287Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT.J Nucl Med2016https://conductscience.org/library/papers/26795287PubMed
734248856Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34248856PubMed
835588757Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.Lancet Diabetes Endocrinol2022https://conductscience.org/library/papers/35588757PubMed
921197715Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans.Transplantation2010https://conductscience.org/library/papers/21197715PubMed
1030767048Beta cells in type 1 diabetes: mass and function; sleeping or dead?Diabetologia2019https://conductscience.org/library/papers/30767048PubMed
1134294854Distinctive detection of insulinoma using [18F]FB(ePEG12)12-exendin-4 PET/CT.Sci Rep2021https://conductscience.org/library/papers/34294854PubMed
1233737913In Vivo Imaging of Pancreatic Islet Grafts in Diabetes Treatment.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/33737913PubMed
1320146667Development of radiotracers for the determination of the beta-cell mass in vivo.Curr Pharm Des2010https://conductscience.org/library/papers/20146667PubMed
1425409700(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell mass.Diabetes2015https://conductscience.org/library/papers/25409700PubMed
1518211828GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18211828PubMed
1621603240Molecular SPECT Imaging: An Overview.Int J Mol Imaging2011https://conductscience.org/library/papers/21603240PubMed
1732654418Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell.J Diabetes Investig2021https://conductscience.org/library/papers/32654418PubMed
1832323451Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.J Diabetes Investig2020https://conductscience.org/library/papers/32323451PubMed
1934489868First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34489868PubMed
2034835906Exendin-4-Conjugated Manganese Magnetism-Engineered Iron Oxide Nanoparticles as a Potential Magnetic Resonance Imaging Contrast Agent for Tracking Transplanted β-Cells.Nanomaterials (Basel)2021https://conductscience.org/library/papers/34835906PubMed

See all 39 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42330301Response to Comment on Sakaki et al. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.Diabetes2026https://conductscience.org/library/papers/42330301PubMed
40454554A novel subcutaneous islet transplantation method using a bioabsorbable medical device to facilitate the creation of a highly vascularized transplantation site.Cell Transplant2025https://conductscience.org/library/papers/40454554PubMed
36906290Noninvasive quantitative evaluation of viable islet grafts using 111 In-exendin-4 SPECT/CT.FASEB J2023https://conductscience.org/library/papers/36906290PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36906290

GET https://conductscience.org/api/papers/v1/36906290/references?page=2